252 related articles for article (PubMed ID: 25596843)
1. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ.
Strobel S; Grünblatt E; Riederer P; Heinsen H; Arzberger T; Al-Sarraj S; Troakes C; Ferrer I; Monoranu CM
J Neural Transm (Vienna); 2015 Jul; 122(7):1069-76. PubMed ID: 25596843
[TBL] [Abstract][Full Text] [Related]
2. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
3. TREM2 and the Progression of Alzheimer's Disease.
Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
[TBL] [Abstract][Full Text] [Related]
4. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.
Jiang T; Yu JT; Zhu XC; Tan MS; Gu LZ; Zhang YD; Tan L
Neurobiol Aging; 2014 Jun; 35(6):1243-51. PubMed ID: 24368090
[TBL] [Abstract][Full Text] [Related]
5. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
6. TREMs in Alzheimer's disease: Genetic and clinical investigations.
Cheng J; Guo X; Zhang T; Zhong L; Bu G; Chen X
Clin Chim Acta; 2016 Dec; 463():88-95. PubMed ID: 27769848
[TBL] [Abstract][Full Text] [Related]
7. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
8. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus.
Celarain N; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Larumbe R; Pulido L; Echavarri C; Mendioroz M
Clin Epigenetics; 2016; 8():37. PubMed ID: 27051467
[TBL] [Abstract][Full Text] [Related]
9. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
Casati M; Ferri E; Gussago C; Mazzola P; Abbate C; Bellelli G; Mari D; Cesari M; Arosio B
Eur J Neurol; 2018 Jun; 25(6):805-810. PubMed ID: 29377401
[TBL] [Abstract][Full Text] [Related]
12. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore.
Gussago C; Casati M; Ferri E; Arosio B
J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915
[TBL] [Abstract][Full Text] [Related]
13. The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia.
Roussos P; Katsel P; Fam P; Tan W; Purohit DP; Haroutunian V
Alzheimers Dement; 2015 Oct; 11(10):1163-70. PubMed ID: 25499537
[TBL] [Abstract][Full Text] [Related]
14. CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer's disease.
Zhang L; Xu J; Gao J; Wu Y; Yin M; Zhao W
Rev Neurosci; 2018 Nov; 29(8):837-848. PubMed ID: 29729150
[TBL] [Abstract][Full Text] [Related]
15. TREM2 regulates innate immunity in Alzheimer's disease.
Li JT; Zhang Y
J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369
[TBL] [Abstract][Full Text] [Related]
16. Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease.
Perez SE; Nadeem M; He B; Miguel JC; Malek-Ahmadi MH; Chen K; Mufson EJ
Neurobiol Aging; 2017 Jun; 54():133-143. PubMed ID: 28365005
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
Ozaki Y; Yoshino Y; Yamazaki K; Sao T; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
J Psychiatr Res; 2017 Sep; 92():74-80. PubMed ID: 28412600
[TBL] [Abstract][Full Text] [Related]
18. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
19. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
20. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.
Colonna M; Wang Y
Nat Rev Neurosci; 2016 Apr; 17(4):201-7. PubMed ID: 26911435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
